S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.55
+1.87
+11.21%
SRRK · Scholar Rock Holding Corporation
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Scholar Rock Holding Corp (SRRK)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$43.06
+1.66
(+4.00%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$43.06
$41.63
$43.20
52-WEEK RANGE
$43.06
$27.07
$61.76
What's happening
- SRRK is up 4.00% today, trading at $43.06. — Live quote
- Volume today (148,790) is well below its 3-month average of 1,618,600. (Finnhub fundamentals)
- Reports earnings on 2026-11-18, 27 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.84 actual vs. $-0.86 estimated (+2.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 9
Buy 13
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (24 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SRRK
-6.11%
vs S&P 500
-18.88%
1-YEAR RETURN
SRRK
+48.14%
vs S&P 500
+33.58%
6-MONTH RETURN
SRRK
-17.28%
3-MONTH RETURN
SRRK
-18.71%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.84
Est. $-0.86
BEAT +2.0%
2026-04-26 (Q1 2026)
$-0.83
Est. $-0.82
MISS -1.6%
2026-01-26 (Q4 2025)
$-0.88
Est. $-0.91
BEAT +3.1%
2025-10-26 (Q3 2025)
$-0.90
Est. $-0.86
MISS -5.2%
Valuation Measures & Ratios
Enterprise Value4$4.82B
Forward P/E5—
PEG Ratio6-0.81
Price / Sales (TTM1)107.03
Price / Book725.97
EV4 / Revenue101.94
EV4 / EBITDA—
Profit Margin-236.96%
Operating Margin-231.80%
Return on Equity (ROE8)-159.12%
Return on Assets (ROA9)-86.60%
Avg Volume (3M)1,618,600
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $7.19B | $6.24B | $4.23B | $3.97B | $3.59B |
| P/E | -16.82 | -15.91 | -12.02 | -12.92 | -14.12 |
| Price/Book | 28.35 | 22.62 | 17.25 | 17.04 | 11.51 |
| ROE | -168.51% | -142.20% | -143.45% | -131.91% | -81.50% |
| ROA | -81.69% | -73.33% | -85.36% | -90.50% | -62.46% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short22,722,119
Change from Prior Settlement+17.08%
% of Float—
Days to Cover (Short Ratio)9.32
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +48.1%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -237.0%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-25; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SRRK
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | — | — | — | — | — | — |
| Operating income | -$108.9M | -$102.0M | -$103.5M | -$112.1M | -$77.1M | -$64.8M | -$59.5M | -$58.4M |
| Net income | -$109.9M | -$105.5M | -$102.2M | -$110.0M | -$74.7M | -$64.5M | -$58.5M | -$56.9M |
| EPS (diluted) | $-0.84 | $-0.83 | $-0.90 | $-0.98 | $-0.67 | $-0.66 | $-0.60 | $-0.59 |
| EPS (basic) | $-0.84 | $-0.83 | $-0.90 | $-0.98 | $-0.67 | $-0.66 | $-0.60 | $-0.59 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $523.5M | $535.3M | $404.3M | $411.7M | $340.0M | $407.6M | $474.9M | $179.1M |
| Total liabilities | $269.8M | $259.2M | $158.8M | $166.7M | $106.8M | $95.2M | $106.3M | $99.9M |
| Stockholders' equity | $253.8M | $276.0M | $245.5M | $245.0M | $233.3M | $312.3M | $368.6M | $79.2M |
| Total current assets | $507.2M | $515.3M | $385.1M | $390.7M | $319.1M | $385.2M | $451.2M | $152.9M |
| Total current liabilities | $72.2M | $59.6M | $55.4M | $62.0M | $50.4M | $37.6M | $46.9M | $39.4M |
| Cash & equivalents | $437.1M | $430.5M | $323.5M | $286.8M | $152.9M | $137.9M | $177.9M | $76.4M |
| Marketable securities (current) | $55.0M | $49.4M | $44.0M | $82.9M | $142.1M | $226.4M | $259.4M | $62.7M |
| Accounts receivable | — | — | $2.8M | $3.5M | $2.0M | $1.9M | $2.2M | $1.1M |
| Property, plant & equipment | $1.2M | $1.4M | $1.7M | $2.1M | $2.4M | $2.6M | $2.8M | $3.2M |
| Other non-current assets | $2.8M | $4.6M | $3.2M | $3.3M | $3.0M | $2.9M | $2.9M | $3.8M |
| Accounts payable | $11.0M | $9.2M | $10.3M | $6.8M | $1.1M | $4.4M | $10.1M | $4.1M |
| Accrued liabilities | $54.9M | $44.3M | $39.6M | $49.9M | $44.1M | $27.6M | $31.1M | $29.3M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | $196.2M | $196.6M | $99.7M | $99.6M | $49.8M | $49.7M | $50.1M | $50.1M |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $122.0K | $119.0K | $108.0K | $99.0K | $96.0K | $95.0K | $94.0K | $80.0K |
| Retained earnings | -$1.52B | -$1.41B | -$1.30B | -$1.21B | -$1.11B | -$997.4M | -$922.7M | -$856.3M |
| Accumulated other comprehensive income (loss) | $1.1M | $690.0K | $94.0K | $117.0K | $58.0K | $129.0K | $160.0K | $128.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$70.3M | -$82.1M | -$75.5M | -$68.9M | -$76.9M | -$78.7M | -$49.5M | -$52.5M |
| Investing cash flow | -$5.5M | -$5.3M | $39.0M | $59.7M | $85.5M | $34.6M | -$195.4M | $35.3M |
| Financing cash flow | $83.1M | $193.8M | $73.3M | $144.5M | $6.5M | $4.2M | $346.4M | $166.0K |
| Free cash flow | -$70.3M | -$82.2M | -$75.5M | -$69.0M | -$77.2M | -$78.9M | -$49.5M | -$52.5M |
| Capital expenditures | $1.0K | $68.0K | $32.0K | $84.0K | $215.0K | $271.0K | $22.0K | $31.0K |
| Share-based compensation | $19.7M | $18.2M | $19.4M | $18.3M | $24.4M | $13.4M | $9.5M | $9.7M |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in accounts payable | $1.8M | -$1.1M | $3.5M | $5.7M | -$3.3M | -$5.7M | $6.0M | $756.0K |
| Purchases of investments | $43.0M | $25.3M | $0 | $18.7M | $21.2M | $58.1M | $210.4M | $14.3M |
| Debt issued | $0 | — | $0 | $0 | $1.0K | $24.7M | — | — |
| Debt repaid | $0 | $103.1M | $0 | $0 | $0 | $25.5M | — | — |
| Other financing activities | $0 | — | — | $0 | $0 | $2.0K | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0 | — | — | $33.2M | $18.8M |
| Operating income | -$384.6M | -$252.1M | -$171.3M | -$134.4M | -$129.9M |
| Net income | -$377.9M | -$246.3M | -$165.8M | -$134.5M | -$131.8M |
| EPS (diluted) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 |
| EPS (basic) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 |
| Operating margin | — | — | — | -$405 | -$690 |
| Net margin | — | — | — | -$405 | -$700 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $404.3M | $474.9M | $311.0M | $358.2M | $304.4M |
| Total liabilities | $158.8M | $106.3M | $85.8M | $97.9M | $132.4M |
| Stockholders' equity | $245.5M | $368.6M | $225.2M | $260.2M | $172.1M |
| Total current assets | $385.1M | $451.2M | $288.2M | $328.0M | $265.3M |
| Total current liabilities | $55.4M | $46.9M | $32.7M | $36.4M | $64.3M |
| Cash & equivalents | $323.5M | $177.9M | $101.9M | $103.3M | $212.8M |
| Marketable securities (current) | $44.0M | $259.4M | $178.1M | $212.1M | $40.2M |
| Accounts receivable | $2.8M | $2.2M | $1.1M | $2.7M | — |
| Property, plant & equipment | $1.7M | $2.8M | $4.6M | $7.4M | $9.6M |
| Other non-current assets | $3.2M | $2.9M | $4.4M | $1.7M | $1.6M |
| Accounts payable | $10.3M | $10.1M | $3.5M | $4.0M | $4.4M |
| Accrued liabilities | $39.6M | $31.1M | $20.4M | $24.3M | $17.5M |
| Deferred revenue (current) | — | — | — | — | $33.2M |
| Short-term debt | — | — | $1.3M | — | $1.6M |
| Other current liabilities | — | — | $85.0K | $222.0K | $230.0K |
| Long-term debt | $99.7M | $50.1M | $48.7M | $49.7M | $48.4M |
| Other non-current liabilities | — | — | — | — | — |
| Common stock & paid-in capital | $108.0K | $94.0K | $76.0K | $52.0K | $35.0K |
| Retained earnings | -$1.30B | -$922.7M | -$676.4M | -$510.6M | -$376.1M |
| Accumulated other comprehensive income (loss) | $94.0K | $160.0K | $92.0K | -$884.0K | -$35.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$300.0M | -$200.9M | -$145.2M | -$132.7M | -$126.8M |
| Investing cash flow | $218.7M | -$76.1M | $41.1M | -$171.7M | $134.3M |
| Financing cash flow | $228.4M | $353.0M | $102.6M | $194.8M | $45.0M |
| Free cash flow | -$300.6M | -$201.0M | -$145.3M | -$133.8M | -$132.0M |
| Capital expenditures | $602.0K | $98.0K | $71.0K | $1.1M | $5.2M |
| Share-based compensation | $75.6M | $36.6M | $27.1M | $27.7M | $23.1M |
| Change in accounts receivable | — | — | — | — | — |
| Change in accounts payable | $208.0K | $6.6M | -$529.0K | -$251.0K | $1.0M |
| Purchases of investments | $98.0M | $293.2M | $290.8M | $300.6M | $60.4M |
| Debt issued | $24.7M | — | — | — | — |
| Debt repaid | $25.5M | — | — | — | — |
| Other financing activities | — | — | $3.0K | — | -$20.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SRRK as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-09 to 2026-09-24
Recent transactions
- Insiders have net sold 17,149 shares over the last 182 days, across 0 purchases and 13 sales.
- Most recent: Woods Keith (Chief Operating Officer) — Gift of 48,034 shares on 2026-09-24.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)17,149 sh(13 txns)
Net Shares-17,149
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Woods Keith | Chief Operating Officer | Gift | 2026-09-24 | 48,034 |
| Hallal David | Chief Executive Officer | Gift | 2026-09-21 | 36,652 |
| FLIER JEFFREY S. | Reporting person | Open market sale | 2026-07-01 | 1,568 |
| Gilman Michael | Reporting person | Open market sale | 2026-07-01 | 1,346 |
| Burow Kristina | Reporting person | Open market sale | 2026-07-01 | 2,105 |
| Reed Joshua | Reporting person | Open market sale | 2026-07-01 | 2,105 |
| Peng Katie | Reporting person | Open market sale | 2026-07-01 | 2,988 |
| Brudnick Richard | Director | Grant / award | 2026-06-04 | 6,839 |
| AKKARAJU SRINIVAS | Director | Grant / award | 2026-06-04 | 6,839 |
| Vaishnaw Akshay | President of R&D | Open market sale | 2026-04-16 | 12,246 |
| Sinha Vikas | Chief Financial Officer | Open market sale | 2026-04-16 | 10,410 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Open market sale | 2026-02-23 | 7,427 |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | Open market sale | 2026-02-17 | 4,157 |
| Ho Junlin | GENERAL COUNSEL | Open market sale | 2026-02-17 | 9,580 |
| Parlavecchio Caryn | CHRO | Open market sale | 2026-02-17 | 9,035 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Woods Keith | Chief Operating Officer | Gift | 48,034 | $0.00 |
| 2026-09-21 | Hallal David | Chief Executive Officer | Gift | 36,652 | $0.00 |
| 2026-07-01 | FLIER JEFFREY S. | Reporting person | Open market sale | 1,568 | $53.53 |
| 2026-07-01 | FLIER JEFFREY S. | Reporting person | Open market sale | 1,470 | $54.24 |
| 2026-07-01 | FLIER JEFFREY S. | Reporting person | Open market sale | 15 | $54.88 |
| 2026-07-01 | Gilman Michael | Reporting person | Open market sale | 1,346 | $53.54 |
| 2026-07-01 | Gilman Michael | Reporting person | Open market sale | 1,155 | $54.23 |
| 2026-07-01 | Gilman Michael | Reporting person | Open market sale | 43 | $54.81 |
| 2026-07-01 | Burow Kristina | Reporting person | Open market sale | 2,105 | $53.49 |
| 2026-07-01 | Burow Kristina | Reporting person | Open market sale | 948 | $54.28 |
| 2026-07-01 | Reed Joshua | Reporting person | Open market sale | 2,105 | $53.50 |
| 2026-07-01 | Reed Joshua | Reporting person | Open market sale | 948 | $54.28 |
| 2026-07-01 | Peng Katie | Reporting person | Open market sale | 2,988 | $53.56 |
| 2026-07-01 | Peng Katie | Reporting person | Open market sale | 2,437 | $54.25 |
| 2026-07-01 | Peng Katie | Reporting person | Open market sale | 21 | $54.96 |
| 2026-06-04 | FLIER JEFFREY S. | Director | Grant / award | 6,839 | $0.00 |
| 2026-06-04 | Reed Joshua | Director | Grant / award | 6,839 | $0.00 |
| 2026-06-04 | Brudnick Richard | Director | Grant / award | 6,839 | $0.00 |
| 2026-06-04 | Burow Kristina | Director | Grant / award | 6,839 | $0.00 |
| 2026-06-04 | Gilman Michael | Director | Grant / award | 6,839 | $0.00 |
| 2026-06-04 | Peng Katie | Director | Grant / award | 6,839 | $0.00 |
| 2026-06-04 | AKKARAJU SRINIVAS | Director | Grant / award | 6,839 | $0.00 |
| 2026-04-23 | Burow Kristina | Director | Option exercise | 7,800 | $26.78 |
| 2026-04-23 | Burow Kristina | Director | Option exercise | 28,000 | $4.75 |
| 2026-04-23 | Burow Kristina | Director | Option exercise | 36,000 | $9.11 |
| 2026-04-23 | Burow Kristina | Director | Option exercise | 18,000 | $8.36 |
| 2026-04-16 | Woods Keith | Chief Operating Officer | Open market sale | 10,220 | $49.57 |
| 2026-04-16 | Vaishnaw Akshay | President of R&D | Open market sale | 12,246 | $49.57 |
| 2026-04-16 | Sinha Vikas | Chief Financial Officer | Open market sale | 10,410 | $49.57 |
| 2026-04-16 | Hallal David | Chief Executive Officer | Open market sale | 30,615 | $49.57 |
| 2026-02-23 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Open market sale | 7,427 | $46.94 |
| 2026-02-23 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Open market sale | 857 | $47.86 |
| 2026-02-23 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Open market sale | 200 | $48.48 |
| 2026-02-17 | Marantz Jing L. | CHIEF MEDICAL OFFICER | Open market sale | 4,157 | $46.53 |
| 2026-02-17 | Ho Junlin | GENERAL COUNSEL | Open market sale | 9,580 | $46.53 |
| 2026-02-17 | Parlavecchio Caryn | CHRO | Open market sale | 9,035 | $46.53 |
| 2026-02-17 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Open market sale | 7,989 | $46.53 |
| 2026-02-09 | Vaishnaw Akshay | President of R&D | Grant / award | 47,021 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 09:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-25 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-23 | 4 | 2026-09-21 | View on SEC.gov → |
| 2026-09-15 | 8-K | 2026-09-15 | View on SEC.gov → |
| 2026-09-14 | 8-K | 2026-09-11 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
Recent news
Headlines about SRRK (Scholar Rock Holding Corporation). Links open the publisher — we don’t host full articles.
-
Scholar Rock Holding Corporation (SRRK) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Scholar Rock Holding Corporation (SRRK) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026
Yahoo · 2026-10-20 -
SRRK270115P00045000 Interactive Stock Chart | SRRK Jan 2027 45.000 put Stock - Yahoo Finance
Yahoo! Finance Canada · 2026-10-20 -
How Investors May Respond To Scholar Rock Holding (SRRK) EMA Refile
Simply Wall Street · 2026-10-17 -
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo · 2026-10-16 -
SRRK Oct 2026 30.000 call (SRRK261016C00030000) interactive stock chart
Yahoo Finance UK · 2026-10-16 -
EMA Resubmission for Apitegromab Might Change The Case For Investing In Scholar Rock Holding (SRRK)
Yahoo · 2026-10-16
No headlines in this category right now — try “All”.